Loading clinical trials...
Loading clinical trials...
GEM21menos65. A Phase III Trial for NDMM Patients Who Are Candidates for ASCT Comparing Extended VRD Plus Early Rescue Intervention vs Isatuximab-VRD vs Isatuximab-V-Iberdomide-D
Conditions
Interventions
Bortezomib
Isatuximab
+3 more
Locations
68
Spain
Hospital Principe de Asturias
Alcalá de Henares, Madrid, Spain
Hospital Universitario Quirón Salud Madrid
Pozuelo de Alarcón, Madrid, Spain
Clinica Universidad Navarra (CUN)
Pamplona, Navarre, Spain
Hospital General Universitario de Albacete
Albacete, Spain
Hospital Germans Trias i Pujol (ICO BADALONA)
Badalona, Spain
Hospital Clinic i Provincial de Barcelona
Barcelona, Spain
Start Date
October 1, 2022
Primary Completion Date
April 1, 2027
Completion Date
April 1, 2029
Last Updated
September 28, 2022
NCT05259553
NCT06348147
NCT03733691
NCT05561049
Lead Sponsor
PETHEMA Foundation
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions